These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 20067380)

  • 1. Management of coexisting thyrotropin/growth-hormone-secreting pituitary adenoma and papillary thyroid carcinoma: a therapeutic challenge.
    Nguyen HD; Galitz MS; Mai VQ; Clyde PW; Glister BC; Shakir MK
    Thyroid; 2010 Jan; 20(1):99-103. PubMed ID: 20067380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative long-acting octreotide treatment for invasive thyrotropin-secreting pituitary macroadenoma after previous radioiodine thyroid ablation.
    Gruszka A; Zielinski GM; Kunert-Radek J
    J Clin Neurosci; 2014 Feb; 21(2):340-2. PubMed ID: 23958483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
    Caron P; Arlot S; Bauters C; Chanson P; Kuhn JM; Pugeat M; Marechaud R; Teutsch C; Vidal E; Sassano P
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2849-53. PubMed ID: 11397898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature.
    Yoenem A; Cakyr B; Azal O; Corakcy A; Kutlu M; Oezata M
    Endocr Regul; 1999 Dec; 33(4):169-74. PubMed ID: 10700085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperthyroidism in a patient with TSH-producing pituitary adenoma coexisting with thyroid papillary adenocarcinoma.
    Kishida M; Otsuka F; Kataoka H; Yokota K; Oishi T; Yamauchi T; Doihara H; Tamiya T; Mimura Y; Ogura T; Makino H
    Endocr J; 2000 Dec; 47(6):731-8. PubMed ID: 11228048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma.
    Fukuhara N; Horiguchi K; Nishioka H; Suzuki H; Takeshita A; Takeuchi Y; Inoshita N; Yamada S
    Endocr J; 2015; 62(1):21-7. PubMed ID: 25273395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A challenging TSH/GH co-secreting pituitary adenoma with concomitant thyroid cancer; a case report and literature review.
    Yoon JH; Choi W; Park JY; Hong AR; Kim SS; Kim HK; Kang HC
    BMC Endocr Disord; 2021 Aug; 21(1):177. PubMed ID: 34461869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide).
    Caron P; Gerbeau C; Pradayrol L; Simonetta C; Bayard F
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1164-8. PubMed ID: 8772594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Octreotide in the diagnosis and treatment of pituitary thyrotropin-secreting adenoma].
    Chen S; Li M; Lian XL; Zeng ZP; Dai WX; Li F; Yu W; Wang RZ
    Zhonghua Nei Ke Za Zhi; 2006 Nov; 45(11):910-3. PubMed ID: 17313878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic thyrotropin secreting pituitary adenoma concomitant with papillary thyroid carcinoma: Case report.
    Yang J; Liu S; Yang Z; Shi YB
    Medicine (Baltimore); 2017 Dec; 96(50):e8912. PubMed ID: 29390279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
    Iglesias P; Díez JJ
    J Endocrinol Invest; 1998 Dec; 21(11):775-8. PubMed ID: 9972679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of thyrotropin-producing pituitary adenoma with papillary adenocarcinoma of the thyroid--a case report and surgical strategy.
    Ohta S; Nishizawa S; Oki Y; Namba H
    Pituitary; 2001 Sep; 4(4):271-4. PubMed ID: 12501979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.
    Elisei R; Schlumberger M; Driedger A; Reiners C; Kloos RT; Sherman SI; Haugen B; Corone C; Molinaro E; Grasso L; Leboulleux S; Rachinsky I; Luster M; Lassmann M; Busaidy NL; Wahl RL; Pacini F; Cho SY; Magner J; Pinchera A; Ladenson PW
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4171-9. PubMed ID: 19850694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.
    Molinaro E; Giani C; Agate L; Biagini A; Pieruzzi L; Bianchi F; Brozzi F; Ceccarelli C; Viola D; Piaggi P; Vitti P; Pacini F; Elisei R
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2693-700. PubMed ID: 23626005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
    Boni G; Ferdeghini M; Bellina CR; Matteucci F; Castro Lopez E; Parenti G; Canapicchi R; Bianchi R
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):90-3. PubMed ID: 9002759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macro- and microadenoma of thyrotropin secreting pituitary tumors--two clinical cases.
    Hubalewska-Hola A; Fröss K; Kostecka-Matyja M; Sowa-Staszczak A; Szybiński Z; Huszno B; Ptak M
    Przegl Lek; 2003; 60(11):768-71. PubMed ID: 15058054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
    Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
    Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare case of follicular thyroid carcinoma in a patient with thyrotropin-secreting pituitary adenoma.
    Poggi M; Monti S; Pascucci C; Toscano V
    Am J Med Sci; 2009 Jun; 337(6):462-5. PubMed ID: 19390430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma.
    Wu YY; Chang HY; Lin JD; Chen KW; Huang YY; Jung SM
    J Formos Med Assoc; 2003 Mar; 102(3):164-71. PubMed ID: 12783133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin secreting pituitary adenoma effectively treated with octreotide.
    Fukuda T; Yokoyama N; Tamai M; Imaizumi M; Kimura H; Tominaga T; Ashizawa K; Kiriyama T; Yoshimine H; Ohishi K; Eguchi K
    Intern Med; 1998 Dec; 37(12):1027-30. PubMed ID: 9932634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.